Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia

Journal of the American Society of Hypertension

Volumn 9, Issue 4, 2015, Pages 250-256

  Iwanami, Jun ^a   Mogi, Masaki ^a   Tsukuda, Kana ^a   Wang, Xiao Li ^a   Nakaoka, Hirotomo ^a   Kan No, Harumi ^a   Chisaka, Toshiyuki ^a   Bai, Hui Yu ^a   Shan, Bao Shuai ^a   Kukida, Masayoshi ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral blood flow; cognitive function; inflammation; renin angiotensin system

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR AGONIST; AZILSARTAN; COMPOUND 21; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BENZIMIDAZOLE DERIVATIVE; CCL2 PROTEIN, MOUSE; N-BUTYLOXYCARBONYL-3-(4-IMIDAZOL-1-YLMETHYLPHENYL)-5-ISOBUTYLTHIOPHENE-2-SULFONAMIDE; OXADIAZOLE DERIVATIVE; SULFONAMIDE; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILATERAL COMMON CAROTID ARTERY STENOSIS; BRAIN BLOOD FLOW; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; COGNITION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; MALE; MOUSE; MULTIINFARCT DEMENTIA; NONHUMAN; PRIORITY JOURNAL; SPATIAL LEARNING; AGONISTS; ANIMAL; BLOOD FLOW; BRAIN; BRAIN CORTEX; C57BL MOUSE; DEMENTIA, VASCULAR; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; GENETICS; MAZE TEST; METABOLISM; VASCULARIZATION;

ANIMALS; BENZIMIDAZOLES; BRAIN; CAROTID STENOSIS; CEREBRAL CORTEX; CHEMOKINE CCL2; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; MAZE LEARNING; MICE, INBRED C57BL; OXADIAZOLES; RECEPTOR, ANGIOTENSIN, TYPE 2; REGIONAL BLOOD FLOW; RNA, MESSENGER; SULFONAMIDES; THIOPHENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928418574     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2015.01.010     Document Type: Article

References (23)

1. P.B. Gorelick, A. Scuteri, S.E. Black, C. Decarli, S.M. Greenberg, C. Iadecola American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association Stroke 42 2011 2672 2713
2. J.H. Roh, and J.H. Lee Recent updates on subcortical ischemic vascular dementia J Stroke 16 2014 18 26
3. N.C. Li, A. Lee, R.A. Whitmer, M. Kivipelto, E. Lawler, and L.E. Kazis Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis BMJ 340 2010 b5465
4. N.M. Davies, P.G. Kehoe, Y. Ben-Shlomo, and R.M. Martin Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias J Alzheimers Dis 26 2011 699 708
5. B. Fuentes, J. Fernández-Domínguez, M.A. Ortega-Casarrubios, B. SanJosé, P. Martínez-Sánchez, and E. Díez-Tejedor Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction J Hypertens 28 2010 575 581
6. M. Horiuchi, and M. Mogi Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage Br J Pharmacol 163 2011 1122 1130
7. Y. Wan, C. Wallinder, B. Plouffe, H. Beaudry, A.K. Mahalingam, and X. Wu Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist J Med Chem 47 2004 5995 6008
8. T. Unger, and B. Dahlof Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential J Renin Angiotensin Aldosterone Syst 11 2010 75 77
9. F. Jing, M. Mogi, A. Sakata, J. Iwanami, K. Tsukuda, and K. Ohshima Direct stimulation of angiotensin II type 2 receptor enhances spatial memory J Cereb Blood Flow Metab 32 2012 248 255
10. A. Sakata, M. Mogi, J. Iwanami, K. Tsukuda, L.J. Min, and T. Fujita Sex different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function Brain Res 1300 2009 14 23
11. M. Shibata, R. Ohtani, M. Ihara, and H. Tomimoto White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion Stroke 35 2004 2598 2603
12. M. Ihara, and H. Tomimoto Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes J Aging Res 2011 2011 978761
13. K. Washida, M. Ihara, K. Nishio, Y. Fujita, T. Maki, and M. Yamada Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator activated receptor gamma activation in mice with chronic cerebral hypoperfusion Stroke 41 2010 1798 1806
14. P. Namsolleck, F. Boato, K. Schwengel, L. Paulis, K.S. Matho, and N. Geurts AT2 receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression Neurobiol Dis 51 2013 177 191
15. N. Shraim, B. Mertens, R. Clinckers, S. Sarre, Y. Michotte, and A. Van Eeckhaut Microbore liquid chromatography with UV detection to study the in vivo passage of compound 21, a non-peptidergic AT2 receptor agonist, to the striatum in rats J Neurosci Methods 202 2011 137 142
16. Y. Yang, and G. Rosengerg Blood-brain barrier breakdown in acute and chronic cerebrovascular disease Stroke 42 2011 3323 3328
17. G. Rosenberg Neurological diseases in relation to the blood brain barrier J Cereb Blood Flow Metab 32 2012 1139 1151
18. K. Nakaji, M. Ihara, C. Takahashi, S. Itohara, M. Moda, and R. Takahashi Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents Stroke 37 2006 2816 2823
19. C.L. Bon, and J. Garthwaite On the role of nitric oxide in hippocampal long term potentiation J Neurosci 23 2003 1941 1948
20. R.A. Hopper, and J. Garthwaite Tonic and phasic nitric oxide signals in hippocampal long term potentiation J Neurosci 26 2006 11513 11521
21. V.C. Munk, L. Sanchez de Miguel, M. Petrimpol, N. Butz, A. Banfi, and U. Eriksson Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway Hypertension 49 2007 1178 1185
22. P. Li, T. Kondo, Y. Numaguchi, K. Kobayashi, M. Aoki, and N. Inoue Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis Hypertension 51 2008 252 258
23. A. Alhusban, A.Y. Fouda, Bindu Pillai, T. Ishrat, S. Soliman, and S.C. Fagan Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke J Hypertens 33 2015 170 180